Product image of Nerisona (Diflucortolone Valerate) supplied by GNH India

Nerisona

Active Ingredient:
Diflucortolone Valerate
Origin:
EU

Nerisona (Diflucortolone Valerate)

Diflucortolone Valerate, the active ingredient in Nerisona, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various inflammatory dermatoses, particularly in adult and pediatric patients requiring prescription‑strength therapy.

GNH India supplies Nerisona as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Manufacturer / TM Owner

Leo Pharma A/S

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Diflucortolone Valerate acts on inflammatory pathways of the skin, providing relief in several dermatologic conditions.

  • Eczema: reduces inflammation, redness and itching associated with the condition.
  • Atopic dermatitis: controls flare‑ups and improves skin barrier function.
  • Psoriasis: diminishes plaque formation and scaling.
  • Contact dermatitis: alleviates irritation caused by external allergens.
  • Other inflammatory skin disorders: offers anti‑inflammatory benefit where topical glucocorticoids are indicated.

How It Works

  • Diflucortolone valerate binds to intracellular glucocorticoid receptors, altering gene transcription to suppress pro‑inflammatory cytokines, inhibit phospholipase A2, and reduce prostaglandin and leukotriene synthesis, resulting in anti‑inflammatory, immunosuppressive, and antiproliferative effects in the skin.

Side Effects

Topical application of diflucortolone valerate may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects

  • Burning or stinging sensation at the application site.
  • Mild itching or irritation.
  • Dryness or peeling of the treated skin.

Serious or Rare Side Effects

  • Skin atrophy or thinning with prolonged use.
  • Development of telangiectasia (visible blood vessels).
  • Hypothalamic‑pituitary‑adrenal axis suppression leading to systemic glucocorticoid effects.

Precautions & Warnings

When using diflucortolone valerate, several precautions should be observed to minimize risk.

  • Avoid use on infected or ulcerated skin: may worsen infection.
  • Limit duration of therapy: typically no longer than 2‑4 weeks.
  • Do not apply to broken skin or mucous membranes: increased systemic absorption.
  • Use the smallest effective amount: reduces risk of local side effects.
  • Pregnancy and lactation: safety not established, use only if benefit outweighs risk.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Diflucortolone valerate can interact with other medicines, especially those affecting corticosteroid metabolism or skin integrity.

Major Interactions (Avoid)

  • Systemic corticosteroids: additive systemic glucocorticoid effects.
  • Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase local drug levels.
  • Antifungal agents applied to the same area: risk of enhanced irritation.

Moderate Interactions (Monitor Closely)

  • Topical NSAIDs: may increase local irritation.
  • Photosensitizing agents (e.g., retinoids): heightened risk of phototoxicity.
  • Other topical immunosuppressants (e.g., tacrolimus): additive immunosuppression.

Frequently Asked Questions

Nerisona, containing diflucortolone valerate, is prescribed for inflammatory skin conditions such as eczema, atopic dermatitis, psoriasis, contact dermatitis, and other dermatoses where a potent topical corticosteroid is appropriate.

Diflucortolone valerate binds to glucocorticoid receptors inside skin cells, modulating gene expression to suppress inflammatory mediators, inhibit phospholipase A2, and reduce prostaglandin and leukotriene production, thereby decreasing redness, swelling, and itching.

The specific amount and frequency of Nerisona are determined by the prescribing healthcare professional based on the severity of the skin condition, patient age, and treatment response. No fixed dosing regimen is provided here.

Safety data for diflucortolone valerate in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by a qualified clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Diflucortolone valerate is a high‑potency glucocorticoid, offering stronger anti‑inflammatory effects than low‑ to medium‑potency steroids such as hydrocortisone. It is typically reserved for more severe or resistant dermatoses, whereas milder steroids are used for less intense inflammation.

Store Nerisona at room temperature, preferably below 25 °C, in its original packaging. Protect it from moisture, excessive heat and direct sunlight to maintain product stability and potency.

Nerisona is applied topically to the affected skin area in a thin layer, usually once or twice daily as directed by the prescriber. The skin should be clean and dry before application, and hands should be washed after use.

Serious risks include skin atrophy, development of telangiectasia, and potential systemic effects such as hypothalamic‑pituitary‑adrenal axis suppression, especially with prolonged use, large surface area application, or occlusive dressings.

Nerisona should be avoided in patients with known hypersensitivity to diflucortolone valerate or any formulation components, in the presence of untreated bacterial, viral or fungal skin infections, and on broken or ulcerated skin unless specifically advised by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Diflucortolone Valerate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT